FDA Approved: IBANDRONATE SODIUM — Original Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved Macleods Pharmaceuticals Limited's original ANDA for ibandronate sodium, a bisphosphonate, for the treatment and prevention of osteoporosis in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• IBANDRONATE SODIUM (ibandronate sodium)

Snippet

ORIG AP for IBANDRONATE SODIUM (IBANDRONATE SODIUM)